Takhzyro Prices, Coupons, Copay Cards & Patient Assistance
Takhzyro (lanadelumab) is a member of the hereditary angioedema agents drug class and is commonly used for Hereditary Angioedema.
The cost for Takhzyro (flyo 300 mg/2 mL) subcutaneous solution is around $27,522 for a supply of 2 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Takhzyro prices
Subcutaneous Solution
flyo 300 mg/2 mL
Takhzyro subcutaneous solution
from $27,521.50
for 2 milliliters
Quantity | Per unit | Price |
---|---|---|
2 milliliters | $13,760.75 | $27,521.50 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Takhzyro Coupons, Copay Cards and Rebates
Takhzyro offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Takhzyro Takeda Patient Support Program
Eligible commercially insured patients may get up to 100% of their out-of-pocket co-pay costs covered, with savings up to $20,000 per year.
- Applies to:
- Takhzyro
- Number of uses:
- Per prescription per calendar year
Form more information phone: 866-888-0660 or Visit website
Patient Assistance & Copay Programs for Takhzyro
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Takeda Patient Support
Eligibility requirements:- Determined case by case
- Based on FPL
- FDA-approved diagnosis
- Must be residing in the US or a US territory, and under the care of a US physician
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
- Takhzyro (lanadelumab) Injection; Subcutaneous
More information please phone: 877-825-3327 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Takhzyro (lanadelumab)
- Check interactions
- Compare alternatives
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- Breastfeeding
- En español